<p>Cilj ove doktorske disertacije je&nbsp; bila&nbsp; sinteza novih steroidnih&nbsp;16,17-seko-16,17a-dinitrila polazeći od&nbsp;dehidroepiandrosterona (1), odnosno&nbsp; estrona (14).&nbsp; U&nbsp;androstanskoj seriji&nbsp; su izvr&scaron;ene modifikacije&nbsp; 16,17-seko-16,17a-dinitrila&nbsp; 12&nbsp; u A i/ili B prstenu steroidnog jezgra, pri&nbsp;čemu novosintetizovana jedinjenja&nbsp; sadrže&nbsp; 4-en-3-on, 1,4-dien-3-on ili 1,4,6-trien-3-on sistem, kao i supstituente u&nbsp;položajima C-4, odnosno C-6&nbsp; (6-metilen, 6-keto i 6-oksimino).&nbsp; U&nbsp; radu&nbsp; je takođe&nbsp; proučavan&nbsp; uticaj odabranih&nbsp;novosintetizovanih jedinjenja na proliferaciju sedam ćelijskih&nbsp;linija humanih tumora, dok je kao kontrola služila jedna&nbsp;zdrava humana ćelijska linija.</p> / <p>Starting from dehydroepiandrosterone (1) or estrone (14)&nbsp;new steroidal 16,17-seco-16,17a-dinitriles&nbsp; were&nbsp;synthesized. Modification of 16,17-seco-16,17a-dinitrile&nbsp;12&nbsp; afforded&nbsp; androstane derivatives containing 4-en-3-on,&nbsp;1,4-dien-3-on or 1,4,6-trien-3-on system,&nbsp; with&nbsp; different&nbsp;substituents on position C-4 or C-6 (6-methylene, 6-keto i&nbsp;6-oximino).&nbsp; Antiproliferative activity&nbsp; of&nbsp; some&nbsp; newly&nbsp;synthesized&nbsp; compounds were examined&nbsp; against&nbsp; seven&nbsp;human tumor&nbsp; cell lines,&nbsp; while healthy cells&nbsp; served as&nbsp;control.</p>

<p>U&nbsp; ovom&nbsp; radu&nbsp; ostvarene&nbsp; su&nbsp; sinteze C19-derivatizovanih&nbsp; steroidnih&nbsp; D-homo laktona.&nbsp; Takođe,&nbsp; sintetisani&nbsp; su&nbsp; i&nbsp; 5,6-halogeni derivati,&nbsp; 5,6-supstituisani&nbsp; kiseonični&nbsp; derivati,<br />kao&nbsp; i&nbsp; 6,19-epoksi&nbsp; steroidi.&nbsp; Za&nbsp; sva&nbsp; sintetisana jedinjenja&nbsp; je&nbsp; utvrđen&nbsp; antitumorski&nbsp; potencijal ispitivanjem&nbsp; njihove&nbsp; oralne&nbsp; bioraspoloživosti, antiproliferativne&nbsp; aktivnosti&nbsp; na&nbsp; &scaron;est&nbsp; ćelijskih linija&nbsp; kancera,&nbsp; vezivanja&nbsp; za&nbsp; odabrane&nbsp; steroidne receptore&nbsp; i&nbsp; inhibitorne&nbsp; aktivnosti&nbsp; na&nbsp; enzim AKR1C3.</p> / <p>In&nbsp; this&nbsp; paper,&nbsp; a&nbsp; synthesis&nbsp; of&nbsp; C19-derivatized steroidal D-homo lactones has been conducted. 5,6-Halogen derivatives, 5,6-substituted oxygen derivatives&nbsp; and&nbsp; 6,19-epoxy&nbsp; steroids&nbsp; were&nbsp; also synthesized.&nbsp; Antitumor&nbsp; potential&nbsp; was determined&nbsp; for&nbsp; all&nbsp; synthesized&nbsp; compounds&nbsp; by examining&nbsp; their&nbsp; oral&nbsp; bioavailability, antiproliferative activity on six cancer cell lines, binding&nbsp; to&nbsp; selected&nbsp; steroid&nbsp; receptors&nbsp; and inhibitor activity on the AKR1C3 enzyme.</p>

<p>Glavni problem u lečenju karcinoma dojke je kako na osnovu kliničke klasifikacije i morfolo&scaron;kih osobina tumora predvideti njegovo dalje pona&scaron;anje. Vrlo često ni kombinacija standardnih prognostičkih faktora ne daje odgovor o potrebi davanja adjuvantne hemioterapije. U cilju sprovođenja adekvatne dalje terapije karcinoma dojke i otkrivanja agresivnih tipova tumora, a nakon hirur&scaron;kog lečenja, postoji stalna potreba za pronalaženjem novih pokazatelja pomoću kojih bi se identifikovale bolesnice koje imaju povećan rizik od razvoja relapsa bolesti. Ciljevi ove studije su bili da se odredi učestalost ekspresije androgenih receptora (AR) u infiltrativnom duktalnom karcinomu dojke. Da se utvrdi povezanost ekspresije AR i kliničko-patolo&scaron;kih prognostičkih faktora u infiltrativnom duktalnom karcinomu dojke. Odnos ekspresije AR i ekspresije estrogen receptora (ER), progesteron receptora (PR) i humanog epidermalnog faktora rasta (HER-2). Da se proceni povezanosti pozitivne ekspresije AR, kao i odnosa AR/ER, sa odgovorom na primenjenu hormonsku terapiju kod ER pozitivnih bolesnica. Da se proceni povezanost ekspresije AR, kao i odnosa AR/ER, sa kliničkim tokom bolesti: pojavom recidiva, metastaza, kao i smrtnim ishodom u toku petogodi&scaron;njeg perioda praćenja pacijentkinja. Istraživanjem je obuhvaćeno oko 200 pacijentkinja obolelih od infiltrativnog duktalnog karcinoma dojke, koje su operisane na Institutu za onkologiju Vojvodine u periodu 2010-2012. godine. Pacijentkinje su odabrane metodom slučajnog izbora. Ne postoji statistički značajna razlika između kliničko patololo&scaron;kih faktora i ekspresije androgenih receptora. Kod pacijentkinja sa infiltrativnim duktalnih karcinomom dojke koje su ER-/AR+ nije pokazana statistički značajna razlika u HER2 proteinskoj ekspresiji. Učestalost receptora za progesteron, estrogen, HER2, Ki-67, tripl negativne ćelija ne karakteri&scaron;u prisustvo androgenskih receptora Nije dokazana statistička značajnost za prvi i drugi stadijum bolesti duktalnog invazivnog karcinoma dojke kada se uzme u obzir kraće vreme preživljavanja kod pacijentkinja koje su primale hormonoterapiju. Statistički značajno kraće vreme preživljavanja pokazano je za treći stadijum bolesti kod pacijentkinja koje su AR i ER (&ge; 2) u odnosu na pacijentkinje kod kojih je odnos AR/ER &lt; 2, čime je za treći stadijum bolesti dokazana inicijalna hipoteza . Analize u prikazanom istraživanju nisu pokazale statističku značajnost kada se porede učestalost relapsa i smrtnog ishoda kada se posmatraju pacijentkinje sa AR pozitivnim i AR negativnim infiltrativnim duktalnim karcinomom dojke. Pokazana je statistički značajna razlika u učestalosti smrtnog ishoda između pacijenatkinja koje su lečene i inhibitorima aromataze i tamoksifenom. Zaključci ove studije bi mogli biti osnova za preporuku da se utvrđivanje ekspresije AR kod karcinoma dojke uvrsti u rutinsku praksu i sadržaj patohistolo&scaron;kog nalaza. Određivanje odnosa ekspresije AR i ER u grupi ER pozitivnih bolesnica moglo bi poslužiti kao vodič za primenu konvencionalne hormonske terapije ili, s druge strane, preporuka za terapiju antiandrogenima, sa ciljem da se izborom novih terapijskih modaliteta pobolj&scaron;a efikasnost lečenja bolesnica sa karcinomom dojke.</p> / <p>The main problem in the treatment of breast cancer is how to predict its future behavior based on the clinical classification and morphological characteristics of the tumor. Very often even a combination of standard prognostic factors does not answer the need for adjuvant chemotherapy. In order to conduct adequate further breast cancer therapy and to detect aggressive tumor types, and following surgical treatment, there is a continuing need to find new indicators to identify patients at increased risk of relapse. The objectives of this study were to determine the frequency of androgen receptor (AR) expression in infiltrative ductal breast cancer. To determine the association between AR expression and clinical-pathological prognostic factors in infiltrative ductal breast cancer. Relationship between AR expression and expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor (HER-2). To evaluate the association of positive AR expression, as well as the AR / ER ratio, with response to hormone therapy in ER positive patients. To evaluate the association of AR expression, as well as the relationship of AR / ER, with the clinical course of the disease: onset of relapse, metastasis, as well as fatal outcome during the 5-year follow-up period. The study included about 200 patients suffering from infiltrative ductal breast cancer, operated on at the Institute of Oncology of Vojvodina in the period 2010-2012. years. Patients were selected by random selection. The results there is no statistically significant difference between clinically pathologic factors and androgen receptor expression. No statistically significant difference in HER2 protein expression was shown in patients with infiltrative ductal breast cancer who are ER- / AR +. The frequency of progesterone receptors, estrogen, HER2, Ki-67, tripl negative cells do not characterize the presence of androgen receptors. No statistical significance was demonstrated for the first and second stages of ductal invasive breast cancer when considering shorter survival times in patients receiving hormone therapy. A statistically significant shorter survival time was shown for the third stage of disease in patients with AR and ER (&ge; 2) compared to patients with an AR / ER ratio of &lt;2, thus proving an initial hypothesis for the third stage of disease. The analyzes in the study presented showed no statistical significance when comparing the incidence of relapse and death when looking at patients with AR positive and AR negative infiltrative ductal breast cancer. There was a statistically significant difference in the incidence of death between patients treated with both aromatase inhibitors and tamoxifen. Conclusions of this study could be the basis for recommending that the determination of AR expression in breast cancer be incorporated into the routine practice and content of pathohistological findings. Determining the ratio of AR and ER expression in a group of ER-positive patients could serve as a guide for the administration of conventional hormone therapy or, on the other hand, a recommendation for anti-androgen therapy, with the aim of improving the effectiveness of breast cancer treatment in the choice of new therapeutic modalities.</p>

<p>Leydig-ove&nbsp; ćelije&nbsp; testisa&nbsp; su&nbsp; primarno&nbsp; mesto&nbsp; sinteze mu&scaron;kih polnih hormona. Ovi hormoni su neophodani za reproduktivno,&nbsp; ali&nbsp; i&nbsp; za&nbsp; op&scaron;te&nbsp; zdravlje&nbsp; budući&nbsp; da&nbsp; su<br />ozbiljni zdravstveni problemi često povezani sa njihovom smanjenom produkcijom.&nbsp; Insulin i insulinu sličan faktor rasta&nbsp; 1,&nbsp; IGF1&nbsp; <em>(engl.</em>&nbsp; insulin&nbsp; like&nbsp; growth&nbsp; factor&nbsp; 1),&nbsp; i<br />signalizacija koju pokreću preko svojih receptora&nbsp; (INSR i IGF1R),&nbsp; su&nbsp; jedan&nbsp; od&nbsp; ključnih&nbsp; faktora&nbsp; koji&nbsp; reguli&scaron;u specifični razvoj tkiva, pa i samih gonada. Ipak,&nbsp; uloga&nbsp; i<br />mehanizmi&nbsp; delovanja&nbsp; ovih&nbsp; receptora&nbsp; u&nbsp; steroidogenim tkivima nisu&nbsp; u potpunosti&nbsp; poznati.&nbsp; Stoga je&nbsp; istraživanje&nbsp; uokviru ove&nbsp; doktorske&nbsp; disertacije&nbsp; koncipirano sa ciljem da se,&nbsp; na&nbsp; modelu&nbsp; prepubertalnih&nbsp; (P21)&nbsp; i&nbsp; adultnih&nbsp; (P80) mužjaka mi&scaron;eva sa kondicionalnom delecijom<em> Insr </em>i <em>Igf1</em>r gena&nbsp; u&nbsp; steroidogenim&nbsp; ćelijama&nbsp; (Insr/Igf1r-DKO), defini&scaron;e uloga INSR i IGF1R u regulisanju diferencijacije i&nbsp; steroidogene&nbsp; funkcije&nbsp; Leydig-ovih&nbsp; ćelija.&nbsp; Pored&nbsp; toga, mužjaci&nbsp; i&nbsp; ženke&nbsp; P21&nbsp; mi&scaron;eva&nbsp; sa&nbsp; istom&nbsp; delecijom&nbsp; su kori&scaron;ćeni&nbsp; za&nbsp; praćenje&nbsp; ekspresije&nbsp; glavnih&nbsp; markera mitohondrijalne&nbsp; biogeneze&nbsp; i&nbsp; fuzije/arhitekture&nbsp; u&nbsp; Leydigovim&nbsp; ćelijama,&nbsp; ovarijumima&nbsp; i&nbsp;&nbsp; nadbubrežnim&nbsp; žlezdama. Rezultati&nbsp; su&nbsp; potvrdili&nbsp; da&nbsp; delecija&nbsp; Insr&nbsp; i&nbsp; Igf1r&nbsp; u<br />steroidogenim&nbsp; tkivima&nbsp; utiče&nbsp; na&nbsp; diferencijaciju&nbsp; i funkcionalne karakteristike Leydig-ovih ćelija P21 i P80 mi&scaron;eva,&nbsp; upućujući&nbsp; na&nbsp; pojavu&nbsp; tzv.&nbsp; &bdquo;feminizacije&ldquo;.&nbsp; Broj<br />Leydig-ovih&nbsp; ćelija&nbsp; izolovanih&nbsp; iz&nbsp; P21&nbsp; i&nbsp; P80&nbsp; Insr/Igf1rDKO&nbsp; mi&scaron;eva&nbsp; bio&nbsp; je&nbsp; smanjen,&nbsp; a&nbsp; morfologija&nbsp; i ultrastruktura&nbsp; ovih&nbsp; ćelija&nbsp; izmenjene&nbsp; kod&nbsp; P21&nbsp; Insr/Igf1rDKO&nbsp; mi&scaron;eva.&nbsp; Steroidogeni&nbsp; kapacitet&nbsp; i&nbsp; aktivnost,&nbsp; kao&nbsp; i ekspresija&nbsp; glavnih&nbsp; elemenata&nbsp; steroidogene&nbsp; ma&scaron;inerije <em>(Lhcgr, Star, Cyp11a1, Cyp17a1, Hsd3b1&nbsp; i&nbsp; 6, Hsd17b3,</em><br /><em>Sf</em>1)&nbsp; bili su&nbsp; smanjeni&nbsp; u Leydig-ovim ćelijama P21 i P80 <em>Insr/Igf1</em>r-DKO mi&scaron;eva,&nbsp; dok je ekspresija transkripcionih represora&nbsp; steroidogeneze&nbsp; (Arr19&nbsp; i&nbsp; Dax1)&nbsp; bila&nbsp; povećana specifično&nbsp; u&nbsp; istim&nbsp; ćelijama,&nbsp; ali&nbsp; ne&nbsp; i&nbsp; u&nbsp; ostatku&nbsp; testisa.<br />Transkripcioni&nbsp; profil&nbsp; markera&nbsp; mu&scaron;kog&nbsp; pola&nbsp; (<em>Sry,&nbsp; Sox9, Amh</em>)&nbsp; bio&nbsp; je&nbsp; izmenjen&nbsp; u Leydig-ovim ćelijama P21 i P80 <em>Insr/Igf1r</em>-DKO&nbsp; mi&scaron;eva.&nbsp; Transkripcija&nbsp; markera&nbsp; ženskog pola (<em>Rspo1, Wnt4</em>) u testisima,&nbsp; kao i ekspresija&nbsp; Cyp19a1 i&nbsp; produkcija estradiola (E2) u Leydig-ovim ćelijama,&nbsp; P21 i&nbsp; P80&nbsp;<em> Insr/Igf1r</em>-DKO&nbsp; mi&scaron;eva&nbsp; bile&nbsp; su&nbsp; povećane. Transkripcija&nbsp; markera&nbsp; mitohondrijalne&nbsp; biogenze (<em>Ppargc1a,&nbsp; Tfam</em>,&nbsp; <em>Mtnd1</em>)&nbsp; bila&nbsp; je&nbsp; smanjena&nbsp; u&nbsp; Leydigovim&nbsp; ćelijama&nbsp; P21&nbsp; <em>Insr/Igf1r</em>-DKO&nbsp; mi&scaron;eva,&nbsp; dok&nbsp; supromene&nbsp; ekspresije&nbsp; izostale&nbsp; u&nbsp; ovarijumima&nbsp; ženki&nbsp; istog&nbsp; genotipa.&nbsp; Isti&nbsp; markeri&nbsp; su&nbsp; bili&nbsp; povećani&nbsp; u&nbsp; nabdubrežnim&nbsp; žlezdama&nbsp; oba&nbsp; pola.&nbsp; Markeri&nbsp; mitohondrijalne fuzije/arhitekture&nbsp; (<em>Mfn1&nbsp; i&nbsp; Mfn2)</em>&nbsp; bili&nbsp; su&nbsp; povećani&nbsp; u Leydig-ovim ćelijama P21 <em>Insr/Igf1r</em>-DKO mi&scaron;eva, &scaron;to je&nbsp; praćeno&nbsp; i&nbsp; naru&scaron;enom&nbsp; mitohondrijalnom&nbsp; fazom steroidogeneze (produkcija progesterona), kao i brojem i&nbsp; morfologijom ovim organela.&nbsp; Ekspresija istih markera u ovarijumima&nbsp; bila&nbsp; je&nbsp; nepromenjena.&nbsp; Sumirano,&nbsp; rezultati ovog istraživanja&nbsp; su&nbsp; pokazali&nbsp; da su&nbsp; INSR i IGF1R&nbsp; važni za&nbsp; diferencijaciju&nbsp; i&nbsp; steroidogenu&nbsp; funkciju&nbsp; Leydig-ovih&nbsp; ćelija&nbsp; P21&nbsp; i&nbsp; P80&nbsp; mi&scaron;eva.&nbsp; Takođe,&nbsp; ovi&nbsp; receptori&nbsp; su&nbsp; važni regulatori&nbsp; markera&nbsp; mitohondrijalne&nbsp; biogeneze&nbsp; i fuzije/arhiteture u steroidogenim ćelijama mu&scaron;kih gonada&nbsp; P21 mi&scaron;eva, ali ne i u steroidogenim ćelijama ovarijuma.&nbsp;</p> / <p>Leydig cells of testes are the primary site of the male sex hormones&nbsp; synthesis.&nbsp; These&nbsp; hormones&nbsp; are&nbsp; indispensable for&nbsp; both&nbsp; reproductive&nbsp; and&nbsp; general&nbsp; health&nbsp; since&nbsp; serious health&nbsp; problems&nbsp; are&nbsp; often&nbsp; associated&nbsp; with&nbsp; their&nbsp; reduced production.&nbsp; Insulin&nbsp; and&nbsp; insulin-like&nbsp; growth&nbsp; factor&nbsp; 1, IGF1&nbsp; (insulin&nbsp; like&nbsp; growth&nbsp; factor&nbsp; 1),&nbsp; and&nbsp; signaling triggered through&nbsp; their receptors (INSR and IGF1R), are&nbsp; one of the key&nbsp; factors&nbsp; that regulate specific development of&nbsp; tissue&nbsp; including&nbsp; gonads.&nbsp; However,&nbsp; the&nbsp; role&nbsp; and mechanisms&nbsp; of&nbsp; these&nbsp; receptors&nbsp; action&nbsp; in&nbsp; steroidogenic tissues are not known enough. This study was designed to&nbsp; observe &nbsp; the role of INSR and IGF1R in regulating the differentiation and steroidogenic function of Leydig cells by using the model of prepubertal (P21) and adult (P80) male mice with the conditional deletion of the&nbsp; Insr&nbsp; and Igf1r&nbsp; genes&nbsp; in&nbsp; steroidogenic&nbsp; cells&nbsp; (<em>Insr/Igf1r-</em>DKO).&nbsp; In addition,&nbsp; male&nbsp; and&nbsp; female&nbsp; P21&nbsp; mice&nbsp; with&nbsp; the&nbsp; samedeletion were used to monitor the expression of the main markers&nbsp; of&nbsp; mitochondrial&nbsp; biogenesis&nbsp; and fusion/architecture&nbsp; in&nbsp; Leydig&nbsp; cells,&nbsp; ovaries&nbsp; and&nbsp; adrenal glands.&nbsp; The&nbsp; results&nbsp; confirmed&nbsp; that&nbsp; deletion&nbsp; of&nbsp;<em> Insr</em>&nbsp; and<em> Igf1r&nbsp;</em> in&nbsp; steroidogenic&nbsp; tissues&nbsp; influences&nbsp; differentiation and&nbsp; functional&nbsp; characteristics&nbsp; of&nbsp; Leydig&nbsp; cells&nbsp; isolated from&nbsp; P21&nbsp; and&nbsp; P80&nbsp; mice,&nbsp; suggesting&nbsp; an&nbsp; appearance&nbsp; of &quot;feminization&quot;.&nbsp; The&nbsp; number&nbsp; of&nbsp; Leydig&nbsp; cells&nbsp; isolated from&nbsp; both&nbsp; P21&nbsp; and&nbsp; P80&nbsp; <em>Insr/Igf1</em>r-DKO&nbsp; mice&nbsp; was reduced.&nbsp; Morphology&nbsp; and&nbsp; ultrastructure&nbsp; of&nbsp; Leydig&nbsp; cells were&nbsp; disturbed&nbsp; in&nbsp; P21&nbsp; <em>Insr/Igf1r-</em>DKO&nbsp; mice. Steroidogenic capacity and activity, as well as expression of the main elements of&nbsp; steroidogenic machinery (<em>Lhcgr, Star, Cyp11a1, Cyp17a1, Hsd3b1&nbsp; and&nbsp; 6, Hsd17b3, Sf1) </em>were&nbsp; decreased&nbsp; in&nbsp; Leydig&nbsp; cells&nbsp; from&nbsp; P21&nbsp; and&nbsp; P80 I<em>nsr/Igf1</em>r-DKO&nbsp; mice,&nbsp; while&nbsp; the&nbsp; expression&nbsp; of transcriptional&nbsp; repressors&nbsp; of&nbsp; steroidogenesis&nbsp; (<em>Arr19</em>&nbsp; and <em>Dax1) </em>was increased&nbsp; in the same cells, but not in the rest of&nbsp; the&nbsp; testes.&nbsp; Transcription&nbsp; profile&nbsp; of&nbsp; the&nbsp; male&nbsp; sex markers&nbsp; (<em>Sry,&nbsp; Sox9</em>,&nbsp; <em>Amh</em>)&nbsp; was&nbsp; altered&nbsp; in&nbsp; Leydig&nbsp; cells from&nbsp; P21&nbsp; and&nbsp; P80&nbsp; <em>Insr/Igf1</em>r-DKO&nbsp; mice.&nbsp; Transcription of the female sex markers (<em>Rspo1, Wnt4</em>) in the testes, as well&nbsp; as&nbsp; <em>Cyp19a1&nbsp; </em>expression&nbsp; and&nbsp; estradiol&nbsp; (E2) production in Leydig cells,&nbsp; from P21 and P80&nbsp; I<em>nsr/Igf1</em>rDKO&nbsp; mice&nbsp; were&nbsp; increased.&nbsp; Transcription&nbsp; of mitochondrial&nbsp; biogenesis&nbsp; markers&nbsp; (<em>Ppargc1a,&nbsp; Tfam, Mtnd1</em>)&nbsp; was&nbsp; declined&nbsp; in&nbsp; Leydig&nbsp; cells&nbsp; from&nbsp; P21<em> Insr/Igf1r-</em>DKO mice, while changes were absent in&nbsp; the ovaries of the same genotype.&nbsp; Transcription of the&nbsp; same markers&nbsp; was&nbsp; increased&nbsp; in&nbsp; the&nbsp; adrenal&nbsp; glands&nbsp; of&nbsp; both sexes.&nbsp; The&nbsp; mitochondrial&nbsp; fusion/architecture&nbsp; markers (<em>Mfn1</em>&nbsp; and&nbsp; <em>Mfn2</em>)&nbsp; were&nbsp; increased&nbsp; in&nbsp; Leydig&nbsp; cells&nbsp; from<em> Insr/Igf1r</em>-DKO&nbsp; mice&nbsp; and&nbsp; followed&nbsp; by&nbsp; disturbedmitochondrial&nbsp; phase&nbsp; of&nbsp; steroidogenesis&nbsp; (progesterone production), as well as&nbsp; decreased&nbsp; number and&nbsp; disturbed morphology&nbsp; of&nbsp; mitochondria.&nbsp;&nbsp; Expression&nbsp; of&nbsp; the&nbsp; same markers&nbsp; in&nbsp; the&nbsp; ovaries&nbsp; was&nbsp; unchanged.&nbsp; In&nbsp; summary, results&nbsp; of&nbsp; this&nbsp; study&nbsp; showed&nbsp; that&nbsp; INSR&nbsp; and&nbsp; IGF1R&nbsp; are important in differentiation and steroidogenic function of Leydig&nbsp; cells&nbsp; from&nbsp; P21&nbsp; and&nbsp; P80&nbsp; mice.&nbsp; Also,&nbsp; these receptors&nbsp; are&nbsp; important&nbsp; regulators&nbsp; of&nbsp; mitochondrial biogenesis&nbsp; and&nbsp;&nbsp; fusion/architecture&nbsp; markers&nbsp; in steroidogenic&nbsp; cells&nbsp; of&nbsp; P21&nbsp; male&nbsp; mice,&nbsp; but&nbsp; not&nbsp; in steroidogenic cells of ovaries.</p>

<p>U ovoj doktorskoj disertaciji ispitane su 1,3-dipolarne<br />cikloadicione reakcije steroidnih azido-nitrila, nitrona i<br />nitril-oksida, pri čemu su sintetizovana različita<br />heterociklična steroidna jedinjenja androstanske i estranske<br />serije. Utvrdjene su strukture novosintetizovanih<br />jedinjenja. Ispitana je biolo&scaron;ka aktivnost odabranih<br />jedinjenja.</p> / <p>In this PhD thesis 1,3-dipolar cycloadditions of<br />steroidal azido-nitriles, nitrones and nitrile-oxide were<br />examined. Various steroidal heterocyclic compounds in<br />the androstane and estrane series were synthesised. The<br />structural characterisation of newly synthesised<br />compounds was done. Biological activity of selected<br />compounds was examined.</p>